C07D 239/94
Nitrogen atoms
C07D239/94 (Nitrogen atoms) appears on 644 US grants and 821 published applications in this corpus.
Search patents in C07D- Granted patents
- 644
- Published applications
- 821
- Assignees
- 399
- Inventors
- 2,309
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 0 | 0 |
| 1978 | 3 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 2 | 0 |
| 1982 | 2 | 0 |
| 1983 | 2 | 0 |
| 1984 | 6 | 0 |
| 1985 | 3 | 0 |
| 1986 | 0 | 0 |
| 1987 | 5 | 0 |
| 1988 | 3 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 3 | 0 |
| 1993 | 7 | 0 |
| 1994 | 3 | 0 |
| 1995 | 4 | 0 |
| 1996 | 4 | 0 |
| 1997 | 6 | 0 |
| 1998 | 16 | 0 |
| 1999 | 11 | 0 |
| 2000 | 9 | 0 |
| 2001 | 17 | 4 |
| 2002 | 24 | 25 |
| 2003 | 20 | 26 |
| 2004 | 11 | 34 |
| 2005 | 14 | 52 |
| 2006 | 22 | 29 |
| 2007 | 19 | 42 |
| 2008 | 18 | 40 |
| 2009 | 19 | 37 |
| 2010 | 19 | 51 |
| 2011 | 25 | 26 |
| 2012 | 24 | 33 |
| 2013 | 38 | 35 |
| 2014 | 33 | 34 |
| 2015 | 26 | 36 |
| 2016 | 28 | 26 |
| 2017 | 25 | 43 |
| 2018 | 25 | 21 |
| 2019 | 22 | 31 |
| 2020 | 25 | 33 |
| 2021 | 18 | 24 |
| 2022 | 18 | 30 |
| 2023 | 10 | 34 |
| 2024 | 19 | 39 |
| 2025 | 19 | 20 |
| 2026 | 9 | 16 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Membrane-active anti-bacterial compounds and uses thereof29 Sep 2026US 12,747,213 B2Regents of the University of Minnesota
- TEAD inhibitors and uses thereof16 Jun 2026US 12,655,150 B2Cedilla Therapeutics, Inc.
- EFGR inhibitor, preparation method therefor and application thereof9 Jun 2026US 12,649,727 B2Abbisko Therapeutics Co., Ltd.
- Salt of arylaminoquinazoline-containing compound, and preparation method therefor and use thereof26 May 2026US 12,637,434 B2Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.
- Amino quinazoline derivatives as P2X3 inhibitors26 May 2026US 12,637,451 B2Chiesi Farmaceutici S.P. A.
- Compound comprising n-methylpiperazine ethanol carbamate structure and use thereof1 Oct 2026US 2026/0297037 A1Korea Institute of Radiological & Medical Sciences
- Modulators of sortilin activity24 Sep 2026US 2026/0285802 A1
- Piperazinyl-Modified Quinazolinyl-Aryl Urea Derivative, And Preparation Method And Use Thereof24 Sep 2026US 2026/0285816 A1Guangxi Normal University
- New compounds and treatment of renal cell carcinoma27 Aug 2026US 2026/0248788 A1Trustlife Therapeutics Inc.
- Quinazoline derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitors27 Aug 2026US 2026/0250304 A1Riboscience LLC
Most cited
By later US patents
- Alkynyl and azido-substituted 4-anilinoquinazolines379US 5,747,498 APfizer Inc. · 1998
- Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase226US 5,480,883 ARhone-Poulenc Rorer Pharmaceuticals Inc. · 1996
- Quinazoline derivatives217US 5,770,599 AZeneca Limited · 1998
- Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase209US 5,409,930 ARhone-Poulenc Rorer Pharmaceuticals Inc. · 1995
- Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase198US 5,710,158 ARhone-Poulenc Rorer Pharmaceuticals Inc. · 1998